+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Computational Biology Market Research Report by Services (Contract and In-house), Application, End User, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) - Global Forecast to 2026 - Cumulative Impact of COVID-19

  • ID: 4896509
  • Report
  • April 2022
  • Region: Global
  • 209 Pages
  • 360iResearch™
UP TO OFF until Dec 31st 2022

FEATURED COMPANIES

  • BGI Group
  • DNAnexus, Inc.
  • Genedata AG
  • Instem
  • PerkinElmer, Inc.
  • Simulation Plus Inc
The Global Computational Biology Market size was estimated at USD 3,212.05 million in 2020, USD 3,813.09 million in 2021, and is projected to grow at a Compound Annual Growth Rate (CAGR) of 18.80% to reach USD 9,031.58 million by 2026.



Market Statistics:


The report provides market sizing and forecast across five major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Market Segmentation & Coverage:


This research report categorizes the Computational Biology to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Services, the market was studied across Contract and In-house.
  • Based on Application, the market was studied across Cellular Biological Simulation, Clinical Trials, Drug Discovery & Disease Modelling, Human Body Simulation Software, and Preclinical Drug Development.
  • Based on End User, the market was studied across Academics and Commercial.
  • Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:


The FPNV Positioning Matrix evaluates and categorizes the vendors in the Computational Biology Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:


The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:


The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Computational Biology Market, including Agilent Technologies, Inc., Applied Biological Materials, Inc., BGI Group, Biomax Informatics AG, Chemical Computing Group Inc., Compugen Ltd, Dassault Systemes, DNAnexus, Inc., DNASTAR, Eurofins Scientific, Gene Network Sciences, Genedata AG, Genomatix, Illumina, Inc., Insilico Biotechnology AG, Instem, Luminex Corporation, Nimbus Discovery Llc, Partek, Inc., PerkinElmer, Inc., QIAGEN, Rosa & Co. Llc, Schrodinger, Simulation Plus Inc, SOPHiA GENETICS, Thermo Fisher Scientific, and Waters Corporation.

The report provides insights on the following pointers:


1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:


1. What is the market size and forecast of the Global Computational Biology Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Computational Biology Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Computational Biology Market?
4. What is the competitive strategic window for opportunities in the Global Computational Biology Market?
5. What are the technology trends and regulatory frameworks in the Global Computational Biology Market?
6. What is the market share of the leading vendors in the Global Computational Biology Market?
7. What modes and strategic moves are considered suitable for entering the Global Computational Biology Market?
Frequently Asked Questions about the Global Computational Biology Market

What is the estimated value of the Global Computational Biology Market?

The Global Computational Biology Market was estimated to be valued at $3212.1 Million in 2020.

What is the growth rate of the Global Computational Biology Market?

The growth rate of the Global Computational Biology Market is 18.8%, with an estimated value of $9031.6 Million by 2026.

What is the forecasted size of the Global Computational Biology Market?

The Global Computational Biology Market is estimated to be worth $9031.6 Million by 2026.

Who are the key companies in the Global Computational Biology Market?

Key companies in the Global Computational Biology Market include Agilent Technologies, Inc., Applied Biological Materials, Inc., BGI Group, Biomax Informatics AG, Chemical Computing Group Inc., Compugen Ltd, Dassault Systemes, DNAnexus, Inc. and Eurofins Scientific.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • BGI Group
  • DNAnexus, Inc.
  • Genedata AG
  • Instem
  • PerkinElmer, Inc.
  • Simulation Plus Inc

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increased Unmet Medical Needs and Rising Demand for Personalized Medicine
5.1.1.2. Expanding use of Computational Tools in Genomics, Epi-genomics, Proteomics, and Meta-genomics
5.1.1.3. Growing Bioinformatics Research and Growing Number of Clinical Studies
5.1.1.4. Adoption of Computational Biology in Oncology Therapeutics
5.1.2. Restraints
5.1.2.1. Dearth of Skilled Professionals to operate Computational Tools
5.1.3. Opportunities
5.1.3.1. Accelerating use of Bioinformatics and Multiscale Biological Modeling in Cell Modelling
5.1.3.2. Increased Funding in Bioinformatics coupled with Advancements in the Field of Computational Biology
5.1.3.3. Rising R&D for drug discovery
5.1.4. Challenges
5.1.4.1. Insufficiency of Interoperability and Multiplatform Capabilities and Lack of Well-Defined Standards and Common Data Formats for the Integration of Data
5.2. Cumulative Impact of COVID-19
6. Computational Biology Market, by Services
6.1. Introduction
6.2. Contract
6.3. In-house
7. Computational Biology Market, by Application
7.1. Introduction
7.2. Cellular Biological Simulation
7.3. Clinical Trials
7.4. Drug Discovery & Disease Modelling
7.5. Human Body Simulation Software
7.6. Preclinical Drug Development
8. Computational Biology Market, by End User
8.1. Introduction
8.2. Academics
8.3. Commercial
9. Americas Computational Biology Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Computational Biology Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
11. Europe, Middle East & Africa Computational Biology Market
11.1. Introduction
11.2. France
11.3. Germany
11.4. Italy
11.5. Netherlands
11.6. Qatar
11.7. Russia
11.8. Saudi Arabia
11.9. South Africa
11.10. Spain
11.11. United Arab Emirates
11.12. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis
12.3. Market Share Analysis, By Key Player
12.4. Competitive Scenario
12.4.1. Merger & Acquisition
12.4.2. Agreement, Collaboration, & Partnership
12.4.3. New Product Launch & Enhancement
12.4.4. Investment & Funding
12.4.5. Award, Recognition, & Expansion
13. Company Usability Profiles
13.1. Agilent Technologies, Inc.
13.2. Applied Biological Materials, Inc.
13.3. BGI Group
13.4. Biomax Informatics AG
13.5. Chemical Computing Group Inc.
13.6. Compugen Ltd
13.7. Dassault Systemes
13.8. DNAnexus, Inc.
13.9. DNASTAR
13.10. Eurofins Scientific
13.11. Gene Network Sciences
13.12. Genedata AG
13.13. Genomatix
13.14. Illumina, Inc.
13.15. Insilico Biotechnology AG
13.16. Instem
13.17. Luminex Corporation
13.18. Nimbus Discovery Llc
13.19. Partek, Inc.
13.20. PerkinElmer, Inc.
13.21. QIAGEN
13.22. Rosa & Co. Llc
13.23. Schrodinger
13.24. Simulation Plus Inc
13.25. SOPHiA GENETICS
13.26. Thermo Fisher Scientific
13.27. Waters Corporation
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing
List of Figures
FIGURE 1. GLOBAL COMPUTATIONAL BIOLOGY MARKET: DYNAMICS
FIGURE 2. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2020 VS 2026 (%)
FIGURE 3. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2020 VS 2026 (USD MILLION)
FIGURE 4. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2026
FIGURE 5. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY CONTRACT, 2018-2026 (USD MILLION)
FIGURE 6. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY CONTRACT, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 7. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY IN-HOUSE, 2018-2026 (USD MILLION)
FIGURE 8. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY IN-HOUSE, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 9. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2020 VS 2026 (%)
FIGURE 10. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2020 VS 2026 (USD MILLION)
FIGURE 11. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2026
FIGURE 12. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY CELLULAR BIOLOGICAL SIMULATION, 2018-2026 (USD MILLION)
FIGURE 13. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY CELLULAR BIOLOGICAL SIMULATION, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 14. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY CLINICAL TRIALS, 2018-2026 (USD MILLION)
FIGURE 15. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY CLINICAL TRIALS, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 16. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY DRUG DISCOVERY & DISEASE MODELLING, 2018-2026 (USD MILLION)
FIGURE 17. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY DRUG DISCOVERY & DISEASE MODELLING, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 18. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY HUMAN BODY SIMULATION SOFTWARE, 2018-2026 (USD MILLION)
FIGURE 19. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY HUMAN BODY SIMULATION SOFTWARE, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 20. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY PRECLINICAL DRUG DEVELOPMENT, 2018-2026 (USD MILLION)
FIGURE 21. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY PRECLINICAL DRUG DEVELOPMENT, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 22. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY END USER, 2020 VS 2026 (%)
FIGURE 23. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY END USER, 2020 VS 2026 (USD MILLION)
FIGURE 24. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY END USER, 2026
FIGURE 25. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY ACADEMICS, 2018-2026 (USD MILLION)
FIGURE 26. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY ACADEMICS, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 27. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY COMMERCIAL, 2018-2026 (USD MILLION)
FIGURE 28. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY COMMERCIAL, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 29. AMERICAS COMPUTATIONAL BIOLOGY MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 30. ARGENTINA COMPUTATIONAL BIOLOGY MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 31. BRAZIL COMPUTATIONAL BIOLOGY MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 32. CANADA COMPUTATIONAL BIOLOGY MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 33. MEXICO COMPUTATIONAL BIOLOGY MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 34. UNITED STATES COMPUTATIONAL BIOLOGY MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 35. ASIA-PACIFIC COMPUTATIONAL BIOLOGY MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 36. AUSTRALIA COMPUTATIONAL BIOLOGY MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 37. CHINA COMPUTATIONAL BIOLOGY MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 38. INDIA COMPUTATIONAL BIOLOGY MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 39. INDONESIA COMPUTATIONAL BIOLOGY MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 40. JAPAN COMPUTATIONAL BIOLOGY MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 41. MALAYSIA COMPUTATIONAL BIOLOGY MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 42. PHILIPPINES COMPUTATIONAL BIOLOGY MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 43. SINGAPORE COMPUTATIONAL BIOLOGY MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 44. SOUTH KOREA COMPUTATIONAL BIOLOGY MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 45. TAIWAN COMPUTATIONAL BIOLOGY MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 46. THAILAND COMPUTATIONAL BIOLOGY MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 47. EUROPE, MIDDLE EAST & AFRICA COMPUTATIONAL BIOLOGY MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 48. FRANCE COMPUTATIONAL BIOLOGY MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 49. GERMANY COMPUTATIONAL BIOLOGY MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 50. ITALY COMPUTATIONAL BIOLOGY MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 51. NETHERLANDS COMPUTATIONAL BIOLOGY MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 52. QATAR COMPUTATIONAL BIOLOGY MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 53. RUSSIA COMPUTATIONAL BIOLOGY MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 54. SAUDI ARABIA COMPUTATIONAL BIOLOGY MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 55. SOUTH AFRICA COMPUTATIONAL BIOLOGY MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 56. SPAIN COMPUTATIONAL BIOLOGY MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 57. UNITED ARAB EMIRATES COMPUTATIONAL BIOLOGY MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 58. UNITED KINGDOM COMPUTATIONAL BIOLOGY MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 59. GLOBAL COMPUTATIONAL BIOLOGY MARKET: FPNV POSITIONING MATRIX
FIGURE 60. GLOBAL COMPUTATIONAL BIOLOGY MARKET: SHARE, BY KEY PLAYER, 2020
FIGURE 61. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL COMPUTATIONAL BIOLOGY MARKET, BY TYPE
List of Tables
TABLE 1. GLOBAL COMPUTATIONAL BIOLOGY MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016–2020
TABLE 3. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2026 (USD MILLION)
TABLE 4. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY CONTRACT, BY REGION, 2018-2026 (USD MILLION)
TABLE 5. AMERICAS COMPUTATIONAL BIOLOGY MARKET SIZE, BY CONTRACT, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 6. UNITED STATES COMPUTATIONAL BIOLOGY MARKET SIZE, BY CONTRACT, BY STATE, 2018-2026 (USD MILLION)
TABLE 7. ASIA-PACIFIC COMPUTATIONAL BIOLOGY MARKET SIZE, BY CONTRACT, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 8. EUROPE, MIDDLE EAST & AFRICA COMPUTATIONAL BIOLOGY MARKET SIZE, BY CONTRACT, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 9. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY IN-HOUSE, BY REGION, 2018-2026 (USD MILLION)
TABLE 10. AMERICAS COMPUTATIONAL BIOLOGY MARKET SIZE, BY IN-HOUSE, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 11. UNITED STATES COMPUTATIONAL BIOLOGY MARKET SIZE, BY IN-HOUSE, BY STATE, 2018-2026 (USD MILLION)
TABLE 12. ASIA-PACIFIC COMPUTATIONAL BIOLOGY MARKET SIZE, BY IN-HOUSE, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 13. EUROPE, MIDDLE EAST & AFRICA COMPUTATIONAL BIOLOGY MARKET SIZE, BY IN-HOUSE, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 14. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2026 (USD MILLION)
TABLE 15. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY CELLULAR BIOLOGICAL SIMULATION, BY REGION, 2018-2026 (USD MILLION)
TABLE 16. AMERICAS COMPUTATIONAL BIOLOGY MARKET SIZE, BY CELLULAR BIOLOGICAL SIMULATION, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 17. UNITED STATES COMPUTATIONAL BIOLOGY MARKET SIZE, BY CELLULAR BIOLOGICAL SIMULATION, BY STATE, 2018-2026 (USD MILLION)
TABLE 18. ASIA-PACIFIC COMPUTATIONAL BIOLOGY MARKET SIZE, BY CELLULAR BIOLOGICAL SIMULATION, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 19. EUROPE, MIDDLE EAST & AFRICA COMPUTATIONAL BIOLOGY MARKET SIZE, BY CELLULAR BIOLOGICAL SIMULATION, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 20. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY CLINICAL TRIALS, BY REGION, 2018-2026 (USD MILLION)
TABLE 21. AMERICAS COMPUTATIONAL BIOLOGY MARKET SIZE, BY CLINICAL TRIALS, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 22. UNITED STATES COMPUTATIONAL BIOLOGY MARKET SIZE, BY CLINICAL TRIALS, BY STATE, 2018-2026 (USD MILLION)
TABLE 23. ASIA-PACIFIC COMPUTATIONAL BIOLOGY MARKET SIZE, BY CLINICAL TRIALS, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 24. EUROPE, MIDDLE EAST & AFRICA COMPUTATIONAL BIOLOGY MARKET SIZE, BY CLINICAL TRIALS, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 25. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY DRUG DISCOVERY & DISEASE MODELLING, BY REGION, 2018-2026 (USD MILLION)
TABLE 26. AMERICAS COMPUTATIONAL BIOLOGY MARKET SIZE, BY DRUG DISCOVERY & DISEASE MODELLING, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 27. UNITED STATES COMPUTATIONAL BIOLOGY MARKET SIZE, BY DRUG DISCOVERY & DISEASE MODELLING, BY STATE, 2018-2026 (USD MILLION)
TABLE 28. ASIA-PACIFIC COMPUTATIONAL BIOLOGY MARKET SIZE, BY DRUG DISCOVERY & DISEASE MODELLING, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 29. EUROPE, MIDDLE EAST & AFRICA COMPUTATIONAL BIOLOGY MARKET SIZE, BY DRUG DISCOVERY & DISEASE MODELLING, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 30. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY HUMAN BODY SIMULATION SOFTWARE, BY REGION, 2018-2026 (USD MILLION)
TABLE 31. AMERICAS COMPUTATIONAL BIOLOGY MARKET SIZE, BY HUMAN BODY SIMULATION SOFTWARE, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 32. UNITED STATES COMPUTATIONAL BIOLOGY MARKET SIZE, BY HUMAN BODY SIMULATION SOFTWARE, BY STATE, 2018-2026 (USD MILLION)
TABLE 33. ASIA-PACIFIC COMPUTATIONAL BIOLOGY MARKET SIZE, BY HUMAN BODY SIMULATION SOFTWARE, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 34. EUROPE, MIDDLE EAST & AFRICA COMPUTATIONAL BIOLOGY MARKET SIZE, BY HUMAN BODY SIMULATION SOFTWARE, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 35. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY PRECLINICAL DRUG DEVELOPMENT, BY REGION, 2018-2026 (USD MILLION)
TABLE 36. AMERICAS COMPUTATIONAL BIOLOGY MARKET SIZE, BY PRECLINICAL DRUG DEVELOPMENT, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 37. UNITED STATES COMPUTATIONAL BIOLOGY MARKET SIZE, BY PRECLINICAL DRUG DEVELOPMENT, BY STATE, 2018-2026 (USD MILLION)
TABLE 38. ASIA-PACIFIC COMPUTATIONAL BIOLOGY MARKET SIZE, BY PRECLINICAL DRUG DEVELOPMENT, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 39. EUROPE, MIDDLE EAST & AFRICA COMPUTATIONAL BIOLOGY MARKET SIZE, BY PRECLINICAL DRUG DEVELOPMENT, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 40. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY END USER, 2018-2026 (USD MILLION)
TABLE 41. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY ACADEMICS, BY REGION, 2018-2026 (USD MILLION)
TABLE 42. AMERICAS COMPUTATIONAL BIOLOGY MARKET SIZE, BY ACADEMICS, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 43. UNITED STATES COMPUTATIONAL BIOLOGY MARKET SIZE, BY ACADEMICS, BY STATE, 2018-2026 (USD MILLION)
TABLE 44. ASIA-PACIFIC COMPUTATIONAL BIOLOGY MARKET SIZE, BY ACADEMICS, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 45. EUROPE, MIDDLE EAST & AFRICA COMPUTATIONAL BIOLOGY MARKET SIZE, BY ACADEMICS, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 46. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY COMMERCIAL, BY REGION, 2018-2026 (USD MILLION)
TABLE 47. AMERICAS COMPUTATIONAL BIOLOGY MARKET SIZE, BY COMMERCIAL, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 48. UNITED STATES COMPUTATIONAL BIOLOGY MARKET SIZE, BY COMMERCIAL, BY STATE, 2018-2026 (USD MILLION)
TABLE 49. ASIA-PACIFIC COMPUTATIONAL BIOLOGY MARKET SIZE, BY COMMERCIAL, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 50. EUROPE, MIDDLE EAST & AFRICA COMPUTATIONAL BIOLOGY MARKET SIZE, BY COMMERCIAL, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 51. AMERICAS COMPUTATIONAL BIOLOGY MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 52. ARGENTINA COMPUTATIONAL BIOLOGY MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 53. BRAZIL COMPUTATIONAL BIOLOGY MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 54. CANADA COMPUTATIONAL BIOLOGY MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 55. MEXICO COMPUTATIONAL BIOLOGY MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 56. UNITED STATES COMPUTATIONAL BIOLOGY MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 57. ASIA-PACIFIC COMPUTATIONAL BIOLOGY MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 58. AUSTRALIA COMPUTATIONAL BIOLOGY MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 59. CHINA COMPUTATIONAL BIOLOGY MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 60. INDIA COMPUTATIONAL BIOLOGY MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 61. INDONESIA COMPUTATIONAL BIOLOGY MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 62. JAPAN COMPUTATIONAL BIOLOGY MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 63. MALAYSIA COMPUTATIONAL BIOLOGY MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 64. PHILIPPINES COMPUTATIONAL BIOLOGY MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 65. SINGAPORE COMPUTATIONAL BIOLOGY MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 66. SOUTH KOREA COMPUTATIONAL BIOLOGY MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 67. TAIWAN COMPUTATIONAL BIOLOGY MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 68. THAILAND COMPUTATIONAL BIOLOGY MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 69. EUROPE, MIDDLE EAST & AFRICA COMPUTATIONAL BIOLOGY MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 70. FRANCE COMPUTATIONAL BIOLOGY MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 71. GERMANY COMPUTATIONAL BIOLOGY MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 72. ITALY COMPUTATIONAL BIOLOGY MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 73. NETHERLANDS COMPUTATIONAL BIOLOGY MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 74. QATAR COMPUTATIONAL BIOLOGY MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 75. RUSSIA COMPUTATIONAL BIOLOGY MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 76. SAUDI ARABIA COMPUTATIONAL BIOLOGY MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 77. SOUTH AFRICA COMPUTATIONAL BIOLOGY MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 78. SPAIN COMPUTATIONAL BIOLOGY MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 79. UNITED ARAB EMIRATES COMPUTATIONAL BIOLOGY MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 80. UNITED KINGDOM COMPUTATIONAL BIOLOGY MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 81. GLOBAL COMPUTATIONAL BIOLOGY MARKET: SCORES
TABLE 82. GLOBAL COMPUTATIONAL BIOLOGY MARKET: BUSINESS STRATEGY
TABLE 83. GLOBAL COMPUTATIONAL BIOLOGY MARKET: PRODUCT SATISFACTION
TABLE 84. GLOBAL COMPUTATIONAL BIOLOGY MARKET: RANKING
TABLE 85. GLOBAL COMPUTATIONAL BIOLOGY MARKET: SHARE, BY KEY PLAYER, 2020
TABLE 86. GLOBAL COMPUTATIONAL BIOLOGY MARKET: MERGER & ACQUISITION
TABLE 87. GLOBAL COMPUTATIONAL BIOLOGY MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 88. GLOBAL COMPUTATIONAL BIOLOGY MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 89. GLOBAL COMPUTATIONAL BIOLOGY MARKET: INVESTMENT & FUNDING
TABLE 90. GLOBAL COMPUTATIONAL BIOLOGY MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 91. GLOBAL COMPUTATIONAL BIOLOGY MARKET: LICENSE & PRICING
Note: Product cover images may vary from those shown
  • Agilent Technologies, Inc.
  • Applied Biological Materials, Inc.
  • BGI Group
  • Biomax Informatics AG
  • Chemical Computing Group Inc.
  • Compugen Ltd
  • Dassault Systemes
  • DNAnexus, Inc.
  • DNASTAR
  • Eurofins Scientific
  • Gene Network Sciences
  • Genedata AG
  • Genomatix
  • Illumina, Inc.
  • Insilico Biotechnology AG
  • Instem
  • Luminex Corporation
  • Nimbus Discovery Llc
  • Partek, Inc.
  • PerkinElmer, Inc.
  • QIAGEN
  • Rosa & Co. Llc
  • Schrodinger
  • Simulation Plus Inc
  • SOPHiA GENETICS
  • Thermo Fisher Scientific
  • Waters Corporation
Note: Product cover images may vary from those shown

Loading
LOADING...